Cross-cultural validation of a prognostic tool: Example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy

BJU International

Volumn 104, Issue 6, 2009, Pages 813-818

  Rouprêt, Morgan ^a,b   Hupertan, Vincent ^b   Comperat, Eva ^a   Drouin, Sarah J ^a   Phé, Véronique ^a   Xylinas, Evanguelos ^a   Demanse, David ^b   Sibony, Mathilde ^a   Richard, Francois ^a   Cussenot, Olivier ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Centre de Recherche sur les Pathologies Prostatiques Group   (France)

Author keywords

Localized prostate cancer; Nomogram; Prognosis; Proportional hazards models; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; DIAGNOSTIC ACCURACY; FOLLOW UP; GLEASON SCORE; HUMAN; KATTAN PREOPERATIVE NOMOGRAM; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY;

AGED; BIOPSY; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 69249090160     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08473.x     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96
2. Bill-Axelson A, Holmberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005 352 : 1977 1984 (Pubitemid 40638368)
3. D'Amico AV, Renshaw AA, Cote K et al. Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease. J Clin Oncol 2004 22 : 3726 3732
4. Partin AW, Kattan MW, Subong EN et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997 277 : 1445 1451
5. Chun FK, Karakiewicz PI, Briganti A et al. Prostate cancer nomograms: an update. Eur Urol 2006 50 : 914 926
6. Kattan MW. Nomograms are difficult to beat. Eur Urol 2008 53 : 671 672
7. Chun FK, Briganti A, Karakiewicz PI, Graefen M. Should we use nomograms to predict outcome? Eur Urol Suppl 2008 : 396 399
8. Guillonneau B. Ceteris paribus and nomograms in medicine. Eur Urol 2007 52 : 1287 1289
9. Hupertan V, Roupret M, Poisson JF et al. Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients. Cancer 2006 107 : 2604 2608
10. Kattan MW. Validating a prognostic model. Cancer 2006 107 : 2523 2524
11. May M, Gunia S, Helke C et al. How far is the preoperative Kattan nomogram applicable for the prediction of recurrence after prostatectomy in patients presenting with PSA levels of more than 20 ng/ml? A validation study. Urol Int 2006 77 : 222 226
12. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998 90 : 766 771
13. Graefen M, Karakiewicz PI, Cagiannos I et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2002 20 : 3206 3212 (Pubitemid 34831516)
14. Greene KL, Meng MV, Elkin EP et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (CAPSURE). J Urol 2004 171 : 2255 9
15. Ohori M, Wheeler TM, Scardino PT. The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer 1994 74 : 104 114
16. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004 23 : 2109 2123
17. Eastham JA, Kattan MW, Fearn P et al. Local progression among men with conservatively treated localized prostate cancer: results from the transatlantic prostate group. Eur Urol 2008 53 : 347 354
18. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002 167 : 528 534
19. Bianco FJ Jr, Kattan MW, Scardino PT, Powell IJ, Pontes JE, Wood DP Jr. Radical prostatectomy nomograms in black American men: accuracy and applicability. J Urol 2003 170 : 73 7
20. Miller R, Ewy W, Corrigan BW et al. How modeling and simulation have enhanced decision making in new drug development. J Pharmacokinet Pharmacodyn 2005 32 : 185 197
21. Briganti A, Gallina A, Suardi N et al. A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer. BJU Int 2008 101 : 556 560
22. Walz J, Gallina A, Perrotte P et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 2007 100 : 1254 1258
23. Stephenson AJ, Scardino PT, Eastham JA et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006 98 : 715 717
24. Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 2003 95 : 634 635